Neonatal Anemia Clinical Trial
Official title:
Effect Evaluation of Different Blood Products Infusion on Neonatal Anemia
The goal of this observational study is to evaluate the clinical efficacy of the transfusion of irradiated red blood cells, washed red blood cells, and leukocyte privative red blood cells, and to study the changes of inflammatory response before and after the transfusion of irradiated red blood cells, washed red blood cells, and leukocyte privative red blood cells in anemic neonates. The main questions it aims to answer are: - Objective evaluation of the advantages and disadvantages of transfusion of different blood products in the treatment of neonatal anemia from the clinical efficacy. - To provide objective basis for clinical rational use of blood in the selection of blood products. Participants will be transfused with fresh irradiated red blood cells, washed red blood cells, and leukocyte privative red blood cells respectively according to relevant clinical and laboratory indicators.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01232387 -
Identification of Early Predictors of Fetomaternal Hemorrhage
|
N/A | |
Completed |
NCT02075970 -
Optimized Erythropoietin (EPO) Treatment
|
Phase 2 | |
Completed |
NCT00731588 -
Red Blood Cell (RBC) Survival Following Transfusion in Infants
|
Phase 2 | |
Completed |
NCT02454101 -
Milking Versus Delayed Cord Clamping in Full Term Neonates
|
N/A |